Literature DB >> 11151027

HIV-1 subtypes among intravenous drug users from two neighboring cities in São Paulo State, Brazil.

M A Rossini1, R S Diaz, M Caseiro, G Turcato, C A Accetturi, E C Sabino.   

Abstract

In order to assess the molecular epidemiology of HIV-1 in two neighboring cities located near the epicenter of the HIV-1 epidemics in Brazil (Santos and São Paulo), we investigated 83 HIV-1 strains obtained from samples collected in 1995 from intravenous drug users. The V3 through V5 region of the envelope of gp 120 was analyzed by heteroduplex mobility analysis. Of the 95 samples, 12 (12.6%) were PCR negative (6 samples from each group); low DNA concentration was the reason for non-amplification in half of these cases. Of the 42 typed cases from São Paulo, 34 (81%, 95% confidence limits 74.9 to 87.0%) were B and 8 (19%, 95% confidence limits 12.9 to 25.0%) were F, whereas of the 41 typed cases from Santos, 39 (95%, 95% confidence limits 91.6 to 98.4%) were B and 2 (5%, 95% confidence limits 1.6 to 8.4%) were C. We therefore confirm the relationship between clade F and intravenous drug use in São Paulo, and the presence of clade C in Santos. The fact that different genetic subtypes of HIV-1 are co-circulating indicates a need for continuous surveillance for these subtypes as well as for recombinant viruses in Brazil.

Entities:  

Mesh:

Year:  2001        PMID: 11151027     DOI: 10.1590/s0100-879x2001000100005

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  2 in total

1.  Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of São Paulo, Brazil.

Authors:  Rosana Alcalde; Monick L Guimarães; Alberto J S Duarte; Jorge Casseb
Journal:  Virol J       Date:  2012-08-09       Impact factor: 4.099

2.  Assessing the HIV-1 Epidemic in Brazilian Drug Users: A Molecular Epidemiology Approach.

Authors:  Monick Lindenmeyer Guimarães; Bianca Cristina Leires Marques; Neilane Bertoni; Sylvia Lopes Maia Teixeira; Mariza Gonçalves Morgado; Francisco Inácio Bastos
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.